Teradata acquired 11% of Aster Data Systems in September, and has agreed to pay an additional $263m for the remaining ownership interest, net of debt and other expenses and including $21m in cash on its book.
Month: March 2011
Creating value through spin-outs
Colin Blaydon and Fred Wainwright, professors, Center for Private Equity and Entrepreneurship at Tuck School of Business, Dartmouth University, draw from proceedings of the National Venture Capital Association Corporate Venture Summit in November 2010 and written up by the Center for Private Equity and Entrepreneurship at Tuck School of Business, Dartmouth University.
Profile: Dow Venture Capital
US-listed chemicals company Dow is an old hand with new tricks when it comes to corporate venturing by moving its strategy towards strategic rather than financial goals.
ArcelorMittal backs Powerit
Family office Black Coral Capital led the round for Powerit Solutions with a consortium including Germany-based conglomerate Siemens, steel company ArcelorMittal’s Clean Technology Fund, and venture capital firms @Ventures and Expansion Capital Partners.
Genomatica causes funding reaction
Bright Capital, the corporate venturing unit of Russia-based industrial conglomerate Ru-Com Group, and US-listed transport company Waste Management are the two corporations in Genomatica’s $45m round.
Optima snaps up its daily deal
Optima Ventures has set up Optima E-Commerce to invest in Octagon Commerce, which now owns the 1SaleADay.com daily deal website and its subsidiaries with 1.5 million customers.
ZBD displays $36m round
Alongside Dow Venture Capital in the round are an undisclosed hedge fund, secondaries investor Coller Capital and venture capital firms DFJ Esprit (after its merger with Prelude), Cody Gate Ventures (which is part-funded by Coller) and TTP Ventures.
Mérieux and Shire back NeuroPhage
NeuroPhage Pharmaceuticals, a US-based developer of drugs for Alzheimer’s disease, has raised $12.4m in its series B round led by Mérieux Développement, the quasi-corporate venturing unit of France-based holding company Institut Mérieux. Ireland-based drugs group Shire also participated in the round, while its $7m A round angel investors also reinvested in the company treating plaques… Continue reading Mérieux and Shire back NeuroPhage
Verizon backs BL Healthcare
Verizon Ventures provided the undisclosed amount of funding to BL Healthcare’s most recent financing round after the company raised $2.9m in 2009’s series A round, according to its regulatory filing.
BlackRock and NTR power up
Jim Barry, chief executive of NTR, will be chief investment officer on the $110bn BlackRock Alternative Investors platform’s new renewable power investment team.
GE backs 1366 Technologies
1366 said it had raised $28.4m in total by adding GE Energy Financial Services, a division of US-listed industrial conglomerate General Electric, and venture capital (VC) firm VantagePoint Venture Partners to its previous consortium.
Google insures against bad weather
The other members of the consortium besides Google Ventures in backing WeatherBill were media-focused investment banks Allen & Company and Code Advisors and venture capital firms Khosla Ventures, New Enterprise Associates, Index Ventures, First Round Capital and Atomico.
Astellas Venture makes ninth exit
Japan-based drugs group Daiichi Sankyo is paying $805m in cash and a further $130m in performance fees for oncology treatment company Plexxikon, which is Astellas Venture Management’s ninth exit.
Thales sees into MultiX
France-based defence group Thales has used its corporate venturing unit to take a 20% stake in MultiX, a maker of X-ray machines for airport security. Thales Corporate Ventures’ purchase of a fifth of MultiX follows its launch in October by Jacques Doremus and Patrick Radisson, both previous employees at Thales Group, with support from the… Continue reading Thales sees into MultiX